The CD19-NKp46-NKCE enhanced NK-cell killing of BCP-ALL blasts (Fig. 4B–D), at levels comparable with those obtained with healthy NK cells (Fig. 3D). This evidence concerns the gene CD19 and acute lymphoblastic leukemia.